Related references
Note: Only part of the references are listed.Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Therapeutic potential of CPI-613 for targeting tumorous mitochondrial energy metabolism and inhibiting autophagy in clear cell sarcoma
Yuki Egawa et al.
PLOS ONE (2018)
Mitochondrial glutamine metabolism via GOT2 supports pancreatic cancer growth through senescence inhibition
Seungyeon Yang et al.
CELL DEATH & DISEASE (2018)
Phosphoinositide 3-Kinase Signaling Pathway in Pancreatic Ductal Adenocarcinoma Progression, Pathogenesis, and Therapeutics
Divya Murthy et al.
FRONTIERS IN PHYSIOLOGY (2018)
Transcriptional Regulation by Nrf2
Claudia Tonelli et al.
ANTIOXIDANTS & REDOX SIGNALING (2018)
Fibroblast Growth Factor 10 in Pancreas Development and Pancreatic Cancer
Rodrick Ndlovu et al.
FRONTIERS IN GENETICS (2018)
Safety and tolerability of the first-in-class agent CPI-613 in combination with modified FOLFIRINOX in patients with metastatic pancreatic cancer: a single-centre, open-label, dose-escalation, phase 1 trial
Angela Alistar et al.
LANCET ONCOLOGY (2017)
Pancreatic cancer cells digest extracellular protein
Peter Sidaway
Nature Reviews Clinical Oncology (2017)
ROS in Cancer: The Burning Question
Iok In Christine Chio et al.
TRENDS IN MOLECULAR MEDICINE (2017)
Mutant Kras- and p16-regulated NOX4 activation overcomes metabolic checkpoints in development of pancreatic ductal adenocarcinoma
Huai-Qiang Ju et al.
NATURE COMMUNICATIONS (2017)
Preclinical efficacy of the novel competitive NAMPT inhibitor STF-118804 in pancreatic cancer
Jair Machado Espindola-Netto et al.
ONCOTARGET (2017)
Escaping Death: Mitochondrial Redox Homeostasis in Cancer Cells
Francesco Ciccarese et al.
FRONTIERS IN ONCOLOGY (2017)
The effect of metformin on survival of patients with pancreatic cancer: a meta-analysis
Xiaogang Li et al.
SCIENTIFIC REPORTS (2017)
Posttranscriptional Upregulation of IDH1 by HuR Establishes a Powerful Survival Phenotype in Pancreatic Cancer Cells
Mahsa Zarei et al.
CANCER RESEARCH (2017)
Metabolic changes associated with tumor metastasis, part 1: tumor pH, glycolysis and the pentose phosphate pathway
Valery L. Payen et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2016)
(Ir)relevance of Metformin Treatment in Patients with Metastatic Pancreatic Cancer: An Open-Label, Randomized Phase II Trial
Michele Reni et al.
CLINICAL CANCER RESEARCH (2016)
Whole Genome Sequencing Defines the Genetic Heterogeneity of Familial Pancreatic Cancer
Nicholas J. Roberts et al.
CANCER DISCOVERY (2016)
Regulation of the Nampt-mediated NAD salvage pathway and its therapeutic implications in pancreatic cancer
Huai-Qiang Ju et al.
CANCER LETTERS (2016)
Pancreatic Cancer: A Review
Cinthya S. Yabar et al.
GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2016)
Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion
Cristovao M. Sousa et al.
NATURE (2016)
A Phase II Clinical Trial of CPI-613 in Patients with Relapsed or Refractory Small Cell Lung Carcinoma
Thomas W. Lycan et al.
PLOS ONE (2016)
Functional annotation of rare gene aberration drivers of pancreatic cancer
Yiu Huen Tsang et al.
NATURE COMMUNICATIONS (2016)
Mutant KRas-Induced Mitochondrial Oxidative Stress in Acinar Cells Upregulates EGFR Signaling to Drive Formation of Pancreatic Precancerous Lesions
Geou-Yarh Liou et al.
CELL REPORTS (2016)
Human Pancreatic Cancer Tumors Are Nutrient Poor and Tumor Cells Actively Scavenge Extracellular Protein
Jurre J. Kamphorst et al.
CANCER RESEARCH (2015)
Metformin in patients with advanced pancreatic cancer: a double-blind, randomised, placebo-controlled phase 2 trial
Sil Kordes et al.
LANCET ONCOLOGY (2015)
Targeting mitochondria metabolism for cancer therapy
Samuel E. Weinberg et al.
NATURE CHEMICAL BIOLOGY (2015)
Pancreatic Cancer Metabolism: Breaking It Down to Build It Back Up
Rushika M. Perera et al.
CANCER DISCOVERY (2015)
Janus-Faced Tumor Microenvironment and Redox
Valery V. Khramtsov et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
Defining normoxia, physoxia and hypoxia in tumours-implications for treatment response
S. R. McKeown
BRITISH JOURNAL OF RADIOLOGY (2014)
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
Lola Rahib et al.
CANCER RESEARCH (2014)
Targeting of NAD Metabolism in Pancreatic Cancer Cells: Potential Novel Therapy for Pancreatic Tumors
Claudia C. S. Chini et al.
CLINICAL CANCER RESEARCH (2014)
A Novel KLF4/LDHA Signaling Pathway Regulates Aerobic Glycolysis in and Progression of Pancreatic Cancer
Min Shi et al.
CLINICAL CANCER RESEARCH (2014)
Mitochondrial response to nutrient availability and its role in metabolic disease
Arwen W. Gao et al.
EMBO MOLECULAR MEDICINE (2014)
Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides
Kivanc Birsoy et al.
NATURE (2014)
The Nrf2 regulatory network provides an interface between redox and intermediary metabolism
John D. Hayes et al.
TRENDS IN BIOCHEMICAL SCIENCES (2014)
Mitochondrial reactive oxygen species and cancer
Lucas B. Sullivan et al.
CANCER & METABOLISM (2014)
The Tumor Microenvironment: Characterization, Redox Considerations, and Novel Approaches for Reactive Oxygen Species-Targeted Gene Therapy
Lucia Laura Policastro et al.
ANTIOXIDANTS & REDOX SIGNALING (2013)
Mitochondrial Dynamics in the Regulation of Nutrient Utilization and Energy Expenditure
Marc Liesa et al.
CELL METABOLISM (2013)
Glutamine-driven oxidative phosphorylation is a major ATP source in transformed mammalian cells in both normoxia and hypoxia
Jing Fan et al.
MOLECULAR SYSTEMS BIOLOGY (2013)
Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells
Cosimo Commisso et al.
NATURE (2013)
Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway
Jaekyoung Son et al.
NATURE (2013)
Detection and molecular analysis of circulating tumor cells for early diagnosis of pancreatic cancer
Chuanli Ren et al.
MEDICAL HYPOTHESES (2013)
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Daniel D. Von Hoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Evolution and dynamics of pancreatic cancer progression
S. Yachida et al.
ONCOGENE (2013)
Strengthened glycolysis under hypoxia supports tumor symbiosis and hexosamine biosynthesis in pancreatic adenocarcinoma
Fabienne Guillaumond et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
HuR is a post-transcriptional regulator of core metabolic enzymes in pancreatic cancer
Richard A. Burkhart et al.
RNA BIOLOGY (2013)
Subcellular localization-dependent changes in EGFP fluorescence lifetime measured by time-resolved flow cytometry
Ali Vaziri Gohar et al.
BIOMEDICAL OPTICS EXPRESS (2013)
Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal Adenocarcinoma
Paolo P. Provenzano et al.
CANCER CELL (2012)
Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism
Haoqiang Ying et al.
CELL (2012)
The Pancreas Cancer Microenvironment
Christine Feig et al.
CLINICAL CANCER RESEARCH (2012)
Physiological Roles of Mitochondrial Reactive Oxygen Species
Laura A. Sena et al.
MOLECULAR CELL (2012)
MUC1 mucin stabilizes and activates hypoxia-inducible factor 1 alpha to regulate metabolism in pancreatic cancer
Nina V. Chaika et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Energy metabolism of cancer: Glycolysis versus oxidative phosphorylation (Review)
Jie Zheng
ONCOLOGY LETTERS (2012)
Deconvoluting the context-dependent role for autophagy in cancer
Eileen White
NATURE REVIEWS CANCER (2012)
Aerobic Glycolysis: Meeting the Metabolic Requirements of Cell Proliferation
Sophia Y. Lunt et al.
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, VOL 27 (2011)
Choosing between glycolysis and oxidative phosphorylation: A tumor's dilemma?
Caroline Jose et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2011)
Pancreatic cancers require autophagy for tumor growth
Shenghong Yang et al.
GENES & DEVELOPMENT (2011)
Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis
Jessie Yanxiang Guo et al.
GENES & DEVELOPMENT (2011)
Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis
Gina M. De Nicola et al.
NATURE (2011)
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Thierry Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Tubular network formation protects mitochondria from autophagosomal degradation during nutrient starvation
Angelika S. Rambold et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Methods in Mammalian Autophagy Research
Noboru Mizushima et al.
CELL (2010)
Eaten alive: a history of macroautophagy
Zhifen Yang et al.
NATURE CELL BIOLOGY (2010)
Pancreatic Cancer
Manuel Hidalgo
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity
Frank Weinberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Regulation Mechanisms and Signaling Pathways of Autophagy
Congcong He et al.
ANNUAL REVIEW OF GENETICS (2009)
Mitochondrial Networking Protects β-Cells From Nutrient-Induced Apoptosis
Anthony J. A. Molina et al.
DIABETES (2009)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
Autophagy is activated in pancreatic cancer cells and correlates with poor patient outcome
Satoshi Fujii et al.
CANCER SCIENCE (2008)
The biology of cancer: Metabolic reprogramming fuels cell growth and proliferation
Ralph J. DeBerardinis et al.
CELL METABOLISM (2008)
Hypoxia signalling controls metabolic demand
M. Christiane Brahimi-Horn et al.
CURRENT OPINION IN CELL BIOLOGY (2007)
Genetics and biology of pancreatic ductal adenocarcinoma
Aram F. Hezel et al.
GENES & DEVELOPMENT (2006)
Both p16Ink4a and the p19Arf-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse
N Bardeesy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia
JW Kim et al.
CELL METABOLISM (2006)
The role of epigenetic alterations in pancreatic cancer
Norihiro Sato et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SURGERY (2006)
Spatial heterogeneity and oxygen dependence of glucose consumption in R3230Ac and fibrosarcomas of the Fischer 344 rat
T Schroeder et al.
CANCER RESEARCH (2005)
Trp53R172H and KraSG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice
SR Hingorani et al.
CANCER CELL (2005)
Mitochondrial O2-• and H2O2 mediate glucose deprivation-induced cytotoxicity and oxidative stress in human cancer cells
IM Ahmad et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Energy substrate modulates mitochondrial structure and oxidative capacity in cancer cells
R Rossignol et al.
CANCER RESEARCH (2004)
The contribution of cytotoxic chemotherapy to 5-year survival in adult malignancies
G Morgan et al.
CLINICAL ONCOLOGY (2004)
Regulation of cancer metastasis by stress pathways
KP Xie et al.
CLINICAL & EXPERIMENTAL METASTASIS (2003)
The IARC TP53 database: New Online mutation analysis and recommendations to users
M Olivier et al.
HUMAN MUTATION (2002)
Share Paper
